Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.

Antiviral therapy - 1 Jan 2006

Antinori Andrea, Trotta Maria Paola, Nasta Paola, Bini Teresa, Bonora Stefano, Castagna Antonella, Zaccarelli Mauro, Quirino Tiziana, Landonio Simona, Merli Stefania, Tozzi Valerio, Di Perri Giovanni, Andreoni Massimo, Perno Carlo Federico, Carosi Giampiero

Abstract excerpt

OBJECTIVES: To evaluate antiviral efficacy of stavudine/tenofovir (d4T/TDF) backbone combination in late-line antiretroviral therapy, and to assess clinical and virological determinants of treatment success. DESIGN: Multicentric retrospective analysis on patients starting d4T/TDF after highly act...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Drug Resistance, Multiple, Viral

Share to Organophosphonates

Share to Stavudine

Share to Tenofovir

Share to Treatment Failure

Source

Identifiers

PMID: 16640104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16640104-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.PMID 16640104Read ↗

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.Semantic proximity Read ↗

Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.Semantic proximity Read ↗

Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine.Semantic proximity Read ↗

Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.Semantic proximity Read ↗

Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy.Semantic proximity Read ↗

Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.Semantic proximity Read ↗

Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V.Semantic proximity Read ↗

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.Semantic proximity Read ↗

Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing RegimensSemantic proximity Read ↗

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.Semantic proximity Read ↗

Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy.Semantic proximity Read ↗

Early virological failure with a combination of tenofovir, didanosine and efavirenz.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.